Product Highlight - VAXIGRIP TETRA

• Indicated for active immunisation of adults, including pregnant women, and children from 6 months of age¹
• Proven immunogenicity against 4 key influenza strains^1-3
• Simple and convenient dosing – subcutaneous or intramuscular administration with 0.5-mL dosing¹
• Suitable for use during breastfeeding¹
• Can be used in all stages of pregnancy*¹

References:
1. VaxigripTetra Singapore prescribing information. Date of revision: May 2022 (NH2022/2023).
2. Gresset-Bourgeois V, et al. Expert Rev Vaccines. 2018;17(1):1-11.
3. Sesay S, et al. Hum Vaccin Immunother. 2018;14(3):596-608.

*Not all infants are protected.

MAT-SG-2300039-V1-Feb 2023